Sowell Financial Services LLC Raises Holdings in CVS Health Co. (NYSE:CVS)


Share on StockTwits

Sowell Financial Services LLC increased its position in shares of CVS Health Co. (NYSE:CVS) by 2.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 42,282 shares of the pharmacy operator’s stock after purchasing an additional 1,107 shares during the quarter. Sowell Financial Services LLC’s holdings in CVS Health were worth $2,888,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Parkside Investments LLC grew its holdings in CVS Health by 7.7% in the 4th quarter. Parkside Investments LLC now owns 93,882 shares of the pharmacy operator’s stock valued at $6,412,000 after buying an additional 6,674 shares in the last quarter. Symphony Financial Ltd. Co. grew its holdings in CVS Health by 15.0% in the 4th quarter. Symphony Financial Ltd. Co. now owns 4,643 shares of the pharmacy operator’s stock valued at $325,000 after buying an additional 607 shares in the last quarter. KMG Fiduciary Partners LLC grew its holdings in CVS Health by 16.4% in the 4th quarter. KMG Fiduciary Partners LLC now owns 60,950 shares of the pharmacy operator’s stock valued at $4,295,000 after buying an additional 8,609 shares in the last quarter. First Citizens Bank & Trust Co. grew its holdings in CVS Health by 5.9% in the 4th quarter. First Citizens Bank & Trust Co. now owns 34,073 shares of the pharmacy operator’s stock valued at $2,328,000 after buying an additional 1,904 shares in the last quarter. Finally, Xcel Wealth Management LLC grew its holdings in CVS Health by 0.7% in the 4th quarter. Xcel Wealth Management LLC now owns 32,140 shares of the pharmacy operator’s stock valued at $2,195,000 after buying an additional 222 shares in the last quarter. Hedge funds and other institutional investors own 74.21% of the company’s stock.

In other CVS Health news, EVP Alan Lotvin sold 25,836 shares of the company’s stock in a transaction dated Friday, January 8th. The stock was sold at an average price of $75.00, for a total transaction of $1,937,700.00. Following the sale, the executive vice president now owns 18,469 shares in the company, valued at approximately $1,385,175. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Lisa Bisaccia sold 25,177 shares of the company’s stock in a transaction dated Tuesday, January 12th. The stock was sold at an average price of $77.00, for a total value of $1,938,629.00. Following the sale, the executive vice president now owns 71,765 shares in the company, valued at approximately $5,525,905. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 58,151 shares of company stock worth $4,375,989. 0.46% of the stock is owned by company insiders.

CVS has been the subject of several analyst reports. BidaskClub upgraded CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 7th. Deutsche Bank Aktiengesellschaft decreased their price target on CVS Health from $104.00 to $101.00 and set a “buy” rating on the stock in a research note on Monday, November 9th. Jefferies Financial Group raised CVS Health from a “hold” rating to a “buy” rating and set a $90.00 price target on the stock in a research note on Friday, January 8th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of CVS Health in a research note on Monday, November 9th. Finally, SVB Leerink upped their price target on CVS Health from $73.00 to $80.00 and gave the company a “market perform” rating in a research note on Monday, December 14th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $82.93.

CVS opened at $74.92 on Thursday. The stock’s 50-day moving average price is $70.55 and its 200 day moving average price is $64.33. CVS Health Co. has a 12-month low of $52.04 and a 12-month high of $77.23. The company has a current ratio of 0.95, a quick ratio of 0.67 and a debt-to-equity ratio of 0.89. The firm has a market cap of $98.06 billion, a price-to-earnings ratio of 12.38, a PEG ratio of 1.69 and a beta of 0.82.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, November 11th. The pharmacy operator reported $1.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.33 by $0.33. CVS Health had a return on equity of 15.60% and a net margin of 2.99%. The firm had revenue of $67.05 billion for the quarter, compared to analyst estimates of $66.54 billion. During the same quarter in the prior year, the company earned $1.84 EPS. CVS Health’s revenue was up 3.5% on a year-over-year basis. On average, research analysts forecast that CVS Health Co. will post 7.43 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, February 1st. Shareholders of record on Friday, January 22nd will be issued a dividend of $0.50 per share. The ex-dividend date is Thursday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.67%. CVS Health’s dividend payout ratio (DPR) is 28.25%.

CVS Health Company Profile

CVS Health Corporation provides health services and plans in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services.

Featured Article: How is a management fee different from a performance fee?

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.